Oxytocin effects in schizophrenia: Reconciling mixed findings and moving forward.
Oxytocin effects in schizophrenia: Reconciling mixed findings and moving forward.
复制标题
DOI:
10.1016/j.neubiorev.2017.05.007
复制
发表时间:
2017-09
影响因子:
8.2
通讯作者:
Woolley JD
中科院分区:
文献类型:
--
作者:
Bradley ER;Woolley JD
Schizophrenia is a severe mental illness that causes major functional impairment. Current pharmacologic treatments are inadequate, particularly for addressing negative and cognitive symptoms of the disorder. Oxytocin, a neuropeptide known to moderate social behaviors, has been investigated as a potential therapeutic for schizophrenia in recent years. Results have been decidedly mixed, leading to controversy regarding oxytocin's utility. In this review, we outline several considerations for interpreting the extant literature and propose a focused agenda for future work that builds on the most compelling findings regarding oxytocin effects in schizophrenia to date. Specifically, we examine underlying causes of heterogeneity in randomized clinical trials (RCTs) conducted thus far and highlight the complexity of the human oxytocin system. We then review evidence of oxytocin's effects on specific deficits in schizophrenia, arguing for further study using objective, precise outcome measures in order to determine whether oxytocin has the potential to improve functional impairment in schizophrenia.
登录
查看更多内容
影响因子:
24.8
作者:
Adolphs, Ralph
通讯作者:
Adolphs, Ralph
影响因子:
10.6
作者:
Andreasen, Nancy C.;Pressler, Marcus;Nopoulos, Peg;Miller, Del;Ho, Beng-Choon
通讯作者:
Ho, Beng-Choon
影响因子:
3.9
作者:
Baron-Cohen, S;O'Riordan, M;Plaisted, K
通讯作者:
Plaisted, K
影响因子:
4.3
作者:
Tabak BA
通讯作者:
Tabak BA
影响因子:
7.6
作者:
Baron-Cohen, S;Wheelwright, S;Plumb, I
通讯作者:
Plumb, I